Table of Portfolio Investments

Aukett Swanke Group plc (AIM:AUK) has a strong foundation in architectural services and is on a transformative journey to become a London-listed provider of Smart Buildings and related services. In 2023 Aukett Swanke acquired technology systems integrator Torpedo Factory Group, workplace technology business Anders+Kern, and energy efficiency software business ecoDriver. ASG is uniquely positioned to ensure the technical systems that run modern premises are designed as an integral part of the structure, from the outset.

Autins is a UK based company that is an industry-leading designer, manufacturer and supplier of acoustic and thermal insulation solutions for the automotive industry and other sectors. It solves complex and challenging acoustic and thermal problems. The Company aims to be responsive and provide cost-effective innovative manufactured solutions. Autins is a company listed on the UK’s AIM stock market. (AIM:AUTG)

Binx has developed a point-of-care diagnostic testing platform to detect chlamydia and gonorrhea. As well as producing the test equipment, Binx provides an online service for patients that includes testing, counselling, treatment, and follow-up.

Conjunct’s Fibre-Lyte product is an innovative Optical Sub-Assembly technology that is used in ultra-high speed data communications and supercomputing. The technology is designed to be used in harsh or safety critical conditions and applications that demand the highest performance at data rates of 25Gbps, 50Gbps and beyond.

Dimensional Imaging provides 3D and 4D image capture systems to the entertainment, medical and other industries. The company’s 4D system offers world-leading facial performance capture. It has been used around the world on award-winning gaming and movie projects.

GyroMetric Systems Limited has developed MDS2™, a patent-protected system of hardware and software. MDS2™ monitors the vibrations in rotating shafts at both high and low speeds and can detect minute irregularities in their motion. The system then analyses the data to predict potential mechanical failure in the shafts and the motors, bearings and couplings attached to them. It currently supplies systems to monitor ship driveshafts and is developing its system for use on very large wind turbines.

Braveheart owns 21.43% of the issued share capital in GyroMetric Systems.

Image Scan Holdings plc is a specialist supplier of X-ray screening systems to the security and industrial inspection markets. It is an operating company whose ordinary shares are admitted to trading on AIM (AIM: IGE). 3DX-RAY, the main trading subsidiary of Image Scan Holdings plc, supplies a range of portable, rapid deployment and static security solutions to the security sector worldwide including Government and private security organisations.

IQ-AI is an imaging software and healthcare diagnostics company, whose subsidiaries include Imaging Biometrics, LLC (“IB”) and Stone Checker Software Limited. IB is a healthcare imaging software company that supplies medical technology solutions, regulatory consulting services and has a neuroimaging product portfolio. Stone Checker Software Limited is a supplier of technology solutions in the field of kidney stone analysis and kidney stone prevention. IQ-AI’s ordinary shares are listed on the main market of the London Stock Exchange (IQAI). IB is undertaking a Phase 1 Clinical Trial of gallium maltolate, a new cancer treatment with the potential to slow brain tumour in patients with relapsed/refractory histologic or molecular glioblastoma.

KDS Architecture Ltd is a central London based Architectural Practice specialising in design completion, compliance audits and design optimisation with a broad range of experience in the residential, hotel, leisure, and commercial sectors involving new build, refurbishment, and listed buildings. Its highly experienced team of 15 Architects and Designers work with many of the UK’s largest contractors and developers to deliver construction projects on site.

NiTech Solutions is a leading authority on the continuous processing of chemicals. Its unique patented reactors and crystallisers are transforming the manufacture of chemicals, pharmaceuticals, food and drink, and biotechnology.

Pyreos has developed a patented thin-film pyro-electric ceramic technology for use in a new range of infra-red sensor products. The technology is used in high-value applications such as motion detectors, gas detection, spectroscopy and infra-red cameras.

With its sister company Nanogenics Ltd., Ryboquin focuses on commercialising patented intellectual property relating to the delivery of gene therapy, primarily to cancer patients. The company hopes to make advances in the safe, effective and regular dosing of all forms of gene therapy so that  chemotherapy  becomes four times more effective than it is currently.

Sentinel Medical has been formed as a spin-out from Paraytec, in order to focus on exploiting ways to detect and monitor bladder cancer. It will use the core technology developed within Paraytec, but build its own team, partnerships and intellectual property.

The company plans to develop a point-of-care instrument that will diagnose and monitor bladder cancer from urine samples.

Braveheart owns 38.40% of the issued share capital in Sentinel Medical.

Vascular Flow Technologies (VFT) is an ISO 13485 Medical Device Development company with unique insight and expertise in pre-clinical development and testing. VFT developed and patented a novel Spiral Laminar Flow™ vascular implant technology which restores the natural pattern of blood flow.

Zilico is developing the next generation of diagnostic devices that remove subjectivity, increase accuracy and deliver results in real-time. These characteristics allow for the improvement and extension of clinical screening programmes globally.  Zilico’s product portfolio is centred on its patented Electrical Impedance Spectroscopy (EIS) technology which has applicability across a wide range of neoplastic conditions. Its ZedScan instrument is a diagnostic system used by the NHS in cervical cancer screening.